Jane Street Group, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 50,500 shares of EYPT stock, worth $328,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,500
Previous 42,586
18.58%
Holding current value
$328,250
Previous $340,000
10.59%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EYPT
# of Institutions
151Shares Held
65.9MCall Options Held
143KPut Options Held
173K-
Cormorant Asset Management, LP Boston, MA8.33MShares$54.1 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$44.1 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$37.4 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$26.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$24.7 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $221M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...